Dry eye disease is increasingly being understood as more than an inflammatory condition alone. TFOS DEWS III emphasizes a driver-based approach to therapy that recognizes the importance of tear film homeostasis, sensory signaling, and lacrimal functional unit integrity.

Join us for an evidence-based discussion on how neuromodulation therapies are reshaping dry eye management by targeting upstream dysfunction within the ocular surface sensory system. Using the dry eye vicious cycle illustration as a clinical framework, this course will examine how restoring physiologic tear stimulation may influence downstream inflammation, tear instability, and patient symptoms.

Attendees will gain practical insight into integrating neuromodulation into comprehensive dry eye treatment plans and learn how to combine therapies based on patient-specific disease drivers and clinical presentation.

This program is supported in part by an independent medical educational grant from Mylan Inc., a Viatris Company.

Speaker: Cory Lapin, O.D., F.A.A.O.

Date: Thursday, September 17, 2026

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: Pending

Cost: Free!

COPE ID: Pending

Category: Pending

This event is undergoing COPE approval for 1 hour CE credit.